METROPOLIS

Metropolis Healthcare Ltd.

NSE: METROPOLIS

BSE: 542650

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

555.95+11.7 (+2.14%)

3 Jul, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

93.2 / 100

Value Score

20.3 / 100

Price Momentum Score

85.6 / 100

QVM Score

82.1 / 100

Key Metrics

Market Cap

11285.10

P/E (TTM)

59.39

P/B

7.46

P/S (TTM)

6.86

EV/EBITDA

28.19

CAPE (5Y)

68.36

ROE (TTM)

13.36

ROCE (TTM)

16.21

ROA (TTM)

9.49

Avg 3Y ROE

12.52

Earnings 3Y CAGR

9.74

Sales 3Y CAGR

12.75

Sales 5Y CAGR

10.52

Debt/Equity

0.15

Consensus TP

610.00

Strong Buy %

38.89

Promoter Holding

48.87

Pledged %

1.18

Stock Analysis

Fundamental analysis overview of Metropolis Healthcare Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 85.6 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

85.6 / 100

Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 1.59% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

High and improving operating margin

The company reported strong operating margin of 16.23% for 12-month ended 31 Mar 2026 and operating margin improved by 162 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 23.64% for 12-month ended 31 Mar 2026 and the growth was 10.08 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 13.56

Value 23.64

-97.35238.8

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 30.57% for 12-month ended 31 Mar 2026 and the growth was 29.43 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.15 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 80.7 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

80.7 / 100

Negative

Expensive and at a premium to industry median P/E

PE TTM of 59.39 indicates that the stock is expensive on a standalone basis and is at a 114.33% premium to industry median P/E

What is P/E Ratio?

Median: 27.71

Value 59.39

6.282638.46

Low dividend yield

The company has a low dividend yield of 0.18%

What is Dividend yield?

Neutral

Moderate and stable ROE

The company reported moderate ROE of 13.36% for 12-month ended 31 Mar 2026 and ROE improved marginally by 140 bps from 1 year ago

What is ROE (FY)?

Financial Snapshot

See detailed analysis

Multi-year trends for Metropolis Healthcare Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Metropolis Healthcare Ltd. Shareholding Pattern

Quarterly breakdown of Metropolis Healthcare Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	56.90	50.81	50.57	50.39	50.38	50.37	50.33	49.50	49.79	49.79	49.76	49.76	49.75	49.75	49.74	49.74	49.67	49.62	49.43	49.40	48.89	48.89	48.89	48.88	48.87
Indian Promoter	56.90	50.81	50.57	50.39	50.38	50.37	50.33	49.50	49.79	49.79	49.76	49.76	49.75	49.75	49.74	49.74	49.67	49.62	49.43	49.40	48.89	48.89	48.89	48.88	48.87
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	22.24	39.59	42.13	41.83	42.97	43.18	42.98	41.41	38.11	37.70	37.95	37.16	39.31	40.55	41.15	42.39	43.76	45.68	46.58	46.73	45.59	45.23	45.62	46.42	46.22
Mutual Funds / UTI	6.01	12.08	13.80	12.75	13.51	12.48	9.67	9.43	14.14	12.76	10.93	11.79	12.38	13.34	14.02	16.01	21.31	23.67	24.33	26.37	26.42	29.81	30.69	32.22	33.28
FI/Bank/Insurance	0.00	1.61	2.12	1.51	1.83	1.73	2.10	1.20	1.18	1.09	0.95	0.94	0.94	1.13	2.40	4.27	3.29	3.49	3.56	3.50	3.75	2.45	2.21	2.16	2.16
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	16.14	25.31	25.44	27.20	27.24	28.59	30.72	30.06	21.91	23.20	25.57	23.86	25.67	25.66	24.29	21.66	18.90	18.25	18.56	16.73	15.29	12.83	12.52	11.68	10.43
Other Institutions	0.09	0.59	0.77	0.37	0.39	0.37	0.49	0.71	0.88	0.65	0.50	0.57	0.32	0.42	0.44	0.45	0.26	0.26	0.13	0.13	0.13	0.14	0.20	0.35	0.36
Non-Institution	20.86	9.60	7.30	7.78	6.65	6.45	6.69	9.09	12.11	12.52	12.30	13.08	10.94	9.70	9.11	7.87	6.57	4.70	3.99	3.87	5.52	5.88	5.49	4.71	4.91
Bodies Corporate	3.13	2.79	2.55	2.36	2.11	1.96	1.69	1.76	2.03	2.23	1.90	1.82	1.61	0.70	0.55	0.59	0.85	0.24	0.14	0.20	1.13	0.27	0.18	0.19	0.19
Others (incl. Retail) No. of shareholders	17.73 21,201	6.81 28,860	4.75 29,175	5.42 35,849	4.54 30,203	4.49 33,052	5.00 42,804	7.33 63,015	10.08 78,657	10.29 85,127	10.40 88,815	11.26 90,233	9.33 83,161	9.00 88,581	8.56 85,225	7.28 78,942	5.72 67,706	4.46 57,719	3.85 51,461	3.67 48,178	4.39 48,929	5.61 49,633	5.31 47,469	4.52 46,308	4.72 48,824

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Smallcap250 Quality 50	1.3%	43 / 50
2	Nifty Microcap 250	0.71%	25 / 250
3	Nifty Total Market	0.03%	410 / 749

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Metropolis Healthcare Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Sushil Shah Family Trust Promoter	June-2025	Inter-se Transfer (Acquisition) 2nd Jun 2025	4.94 %	₹ 0.00	11.67 lac	₹ 0.00
Sushil Shah Family Trust Promoter	June-2025	Inter-se Transfer (Acquisition) 2nd Jun 2025	4.94 %	₹ 0.00	11.67 lac	₹ 0.00
Sushil Kanubhai Shah Promoter & Director	June-2025	Inter-se Transfer (Disposal) 2nd Jun 2025	2.25 %	₹ 0.00	11.67 lac	₹ 0.00
Sushil Kanubhai Shah Promoter & Director	June-2025	Inter-se Transfer (Disposal) 2nd Jun 2025	2.25 %	₹ 0.00	11.67 lac	₹ 0.00
Duru Sushil Shah Promoter Group	March-2025	Inter-se Transfer (Disposal) 28th Mar 2025	1.48 %	₹ 0.00	7.66 lac	₹ 0.00
Duru Shah Family Trust Promoter Group	March-2025	Inter-se Transfer (Acquisition) 28th Mar 2025	9.58 %	₹ 0.00	7.66 lac	₹ 0.00
Sushil Kanubhai Shah Promoter & Director	August-2024	Market Sale (Disposal) 22nd Aug 2024	2.33 %	₹ 2,096.42	17.50 k	₹ 3.67 cr
Sushil Kanubhai Shah Promoter & Director	August-2024	Market Sale (Disposal) 22nd Aug 2024	2.29 %	₹ 2,100.33	7.50 k	₹ 1.58 cr
Sushil Kanubhai Shah Promoter & Director	August-2024	Market Sale (Disposal) 20th Aug 2024	2.38 %	₹ 2,132.28	25.00 k	₹ 5.33 cr
Sushil Kanubhai Shah Promoter & Director	August-2024	Market Sale (Disposal) 20th Aug 2024	2.45 %	₹ 2,059.27	40.00 k	₹ 8.24 cr

…

Corporate Actions

History of Metropolis Healthcare Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 1/share
Record date: 19th May 2026Ex-date: 19th May 2026
Announced on: 13th May 2026
Bonus3 new shares for 1 existing shares
Ex-date: 20th Mar 2026Announced on: 4th Feb 2026
Dividend₹ 4/share
Record date: 11th Nov 2025Ex-date: 11th Nov 2025
Announced on: 5th Nov 2025
Dividend₹ 4/share
Record date: 17th Nov 2023Ex-date: 17th Nov 2023
Announced on: 4th Nov 2023
Dividend₹ 8/share
Record date: 23rd Feb 2023Ex-date: 23rd Feb 2023
Announced on: 3rd Feb 2023

Company Profile

Overview of Metropolis Healthcare Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. It has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological inves...

Key personnel

Mr. Surendran Chemmenkottil

Chief Executive Officer

Mr. Sameer Patel

Chief Financial Officer

Dr. Nilesh Jadavji Shah

President Internal Assurance and Advisor to Chief Executive Officer

Ms. Diya Suri

Chief People Officer

Mr. Pinakin Shah

Chief Information Officer

Mr. Mohan Menon

Chief Marketing Officer

Dr. Kirti Chadha

Chief Scientific Officer, Innovation Officer and Group Head CSR

Mr. Kamlesh Chandrashekhar Kulkarni

Compliance Officer, Company Secretary, Head - Legal and Secretarial

View all

Incorporated on

10 Nov 2000

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

15 Apr 2019

Free Float

10,60,19,984

Website

https://www.metropolisindia.com/

Phone no.

+918422801801

Address

4th Floor, East Wing, Nirlon House,, Dr. Annie Besant Road, Worli,, MUMBAI, 400030, India

Frequently Asked Questions

What is the current share price of Metropolis Healthcare Ltd.?

The current share price of Metropolis Healthcare Ltd. is ₹ 555.95 as of 3 Jul 2026.

What is the market capitalisation of Metropolis Healthcare Ltd.?

The market capitalisation of Metropolis Healthcare Ltd. stands at ₹ 11,285.10 Cr.

What is the PE ratio of Metropolis Healthcare Ltd.?

The Price-to-Earnings (PE) ratio of Metropolis Healthcare Ltd. is 59.39 as of the latest trailing twelve months data.

What is the ROE and ROCE of Metropolis Healthcare Ltd.?

Metropolis Healthcare Ltd. has a Return on Equity (ROE) of 13.36% and a Return on Capital Employed (ROCE) of 16.21% as per the latest financial reports.

What is the 52-week high and low of Metropolis Healthcare Ltd.?

The 52-week high of Metropolis Healthcare Ltd. is - and the 52-week low is -.

What is the dividend yield of Metropolis Healthcare Ltd.?

The dividend yield of Metropolis Healthcare Ltd. is 0.18% based on the current market price.

What is the FII and DII holding in Metropolis Healthcare Ltd.?

Foreign Institutional Investors (FII) hold 10.43%, Domestic Institutional Investors (DII) hold 35.44% and retail/public investors hold 4.72% of Metropolis Healthcare Ltd. shares.

What sector does Metropolis Healthcare Ltd. belong to?

Metropolis Healthcare Ltd. operates in the Healthcare sector. 77.78% of analysts have a Buy or Strong Buy rating on Metropolis Healthcare Ltd. with a consensus target price of ₹ 610.00, implying 12.07% upside from current levels.

What is the beta of Metropolis Healthcare Ltd.?

The beta of Metropolis Healthcare Ltd. is 0.37, indicating its price volatility relative to the broader market. Over the past 1 year, Metropolis Healthcare Ltd. has delivered an absolute return of 28.60%.

What is the RSI of Metropolis Healthcare Ltd.?

The 14-day Relative Strength Index (RSI) of Metropolis Healthcare Ltd. is 54.29, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Metropolis Healthcare Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Metropolis Healthcare Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Holdings and Presence

Company Profile

Stock Analysis

Corporate Actions